John Owen to Purpura, Thrombotic Thrombocytopenic
This is a "connection" page, showing publications John Owen has written about Purpura, Thrombotic Thrombocytopenic.
Connection Strength
1.052
-
Knovich MA, Farland A, Owen J. Long-term management of acquired thrombotic thrombocytopenic purpura using serial plasma ADAMTS13 measurements. Eur J Haematol. 2012 Jun; 88(6):518-25.
Score: 0.410
-
Nicol KK, Shelton BJ, Knovich MA, Owen J. Overweight individuals are at increased risk for thrombotic thrombocytopenic purpura. Am J Hematol. 2003 Nov; 74(3):170-4.
Score: 0.229
-
Kuhlman P, Miller P, Farland A, Owen J, Batt K. Correlating S100B with disease course in a case of new onset, acquired thrombotic thrombocytopenic purpura (TTP): Could this be a new predictive biomarker in TTP? J Clin Apher. 2018 Aug; 33(4):541-545.
Score: 0.155
-
Miller PJ, Farland AM, Knovich MA, Batt KM, Owen J. Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange. Am J Hematol. 2014 Jul; 89(7):695-7.
Score: 0.118
-
Knovich MA, Lawson HL, Burke MH, McCoy TP, Owen J. Rapid quantitative assay of ADAMTS13 activity on an automated coagulation analyzer: clinical applications and comparison with immunoblot method. Am J Hematol. 2008 Aug; 83(8):654-6.
Score: 0.080
-
Knovich MA, Craver K, Matulis MD, Lawson H, Owen J. Simplified assay for VWF cleaving protease (ADAMTS13) activity and inhibitor in plasma. Am J Hematol. 2004 Jul; 76(3):286-90.
Score: 0.060